Identiv (NASDAQ:INVE) reported quarterly sales of $29.00 million which beat the analyst consensus estimate of $27.87 million by 4.06 percent. This is a 1.70 percent increase over sales of $28.52 million the same period last year.
Novo Nordisk To Inject Around DKK16B in API Facility to Boost Late-Phase Product Portfolio
Novo Nordisk A/S (NYSE: NVO) disclosed its plan to i